NIRSEVIMAB vs NIRSEVIMAB-ALIP: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
NIRSEVIMAB vs NIRSEVIMAB-ALIP: Safety Overview
| Metric | NIRSEVIMAB | NIRSEVIMAB-ALIP |
|---|---|---|
| Total FAERS Reports | 247 | 783 |
| Deaths Reported | 5 | 32 |
| Death Rate | 2.0% | 4.1% |
| Hospitalizations | 149 | 281 |
| Average Patient Age | 0.3 yrs | 3.3 yrs |
| % Female Patients | 42.3% | 46.3% |
| Manufacturer | Sanofi Pasteur Inc. | N/A |
| Route | INTRAMUSCULAR | N/A |
| Marketing Status | N/A | Prescription |